通过内皮转移到半细胞,骨质分化和AhR激活促进酸诱导内皮化
Martina Molinaro1, Mario Cozzolino1, Paola Ciceri1
1Laboratory of Experimental Nephrology, Department of Health Sciences, University of Milan, 20142 Milan, Italy.
Toxins
|August 27, 2025
概括
在末期脏疾病 (ESRD) 中,通过激活基碳水化合物受体 (AhR) 途径,Kynurenine会恶化高酸盐诱导的血管化. 这一发现突显了金氨酸
科学领域:
- 肝脏病学
- 心血管生物学
- 细胞生物学
背景情况:
- 末期病患者由于溶液积累而面临高心血管风险.
- 血管化 (VC) 是ESRD的主要并发症,由高血和尿液环境驱动.
- 一种尿素毒素和托芬代谢物Kynurenine可能会恶化VC.
研究的目的:
- 调查金氨酸是否会在人类大动脉内皮细胞 (HAEC) 中增强高酸盐 (Pi) 诱导的化.
主要方法:
- 用Pi和kynurenine治疗HAEC的时间为7天.
- 评估沉积,内皮转化为介质细胞 (EndMT) 和骨质细胞分化.
- 研究了酸受体 (AhR) 途径的作用.
主要成果:
- 基努伦因增加了36%的Pi诱导的沉积.
- 基努伦因增强了EndMT和骨质细胞的分化.
- 基努伦因激活了AhR通路;AhR抑制部分降低了这些效应.
结论:
- 在ESRD中,Kynurenine增强了酸盐诱导的血管化.
- 氨酸碳化合物受体 (AhR) 途径调解氨酸的亲性作用.
- 通过 AhR 信号传递,Kynurenine 通过 AhR 信号传递促进ESRD 内皮功能障碍.
相关概念视频
Osteoclasts in Bone Remodeling
3.2K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.2K
Hormones and Bone Tissue
2.9K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
2.9K
Transducer Mechanism: Enzyme-Linked Receptors
2.8K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.8K
cAMP-dependent Protein Kinase Pathways
6.6K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.6K
Bone Remodeling
38.5K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.5K
PI3K/mTOR/AKT Signaling Pathway
3.9K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.9K


